Loganathan Rangasamy

1.6k total citations
36 papers, 1.3k citations indexed

About

Loganathan Rangasamy is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Loganathan Rangasamy has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Organic Chemistry. Recurrent topics in Loganathan Rangasamy's work include Metal complexes synthesis and properties (12 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Loganathan Rangasamy is often cited by papers focused on Metal complexes synthesis and properties (12 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Loganathan Rangasamy collaborates with scholars based in India, United States and Saudi Arabia. Loganathan Rangasamy's co-authors include Mallayan Palaniandavar, Anvarbatcha Riyasdeen, Eringathodi Suresh, Mohamad Abdulkadhar Akbarsha, Sethu Ramakrishnan, Mani Ganeshpandian, Mohammad Abdulkader Akbarsha, Nattamai S. P. Bhuvanesh, Philip S. Low and Esteban A. Orellana and has published in prestigious journals such as Analytical Biochemistry, International Journal of Molecular Sciences and Inorganic Chemistry.

In The Last Decade

Loganathan Rangasamy

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loganathan Rangasamy India 18 898 600 511 286 153 36 1.3k
Ritankar Majumdar India 23 783 0.9× 415 0.7× 409 0.8× 304 1.1× 394 2.6× 34 1.3k
Catherine M. Clavel Switzerland 20 1.0k 1.1× 1.0k 1.7× 288 0.6× 229 0.8× 187 1.2× 27 1.4k
Suzan Can Germany 14 642 0.7× 883 1.5× 299 0.6× 106 0.4× 164 1.1× 14 1.3k
Hana Kostrhunová Czechia 28 1.2k 1.3× 949 1.6× 610 1.2× 163 0.6× 435 2.8× 82 1.9k
Srividya Swaminathan India 22 629 0.7× 555 0.9× 197 0.4× 179 0.6× 146 1.0× 41 1.2k
Yanglu Chen United States 6 614 0.7× 484 0.8× 314 0.6× 103 0.4× 234 1.5× 8 1.0k
Hannah E. Bridgewater United Kingdom 11 562 0.6× 458 0.8× 211 0.4× 154 0.5× 147 1.0× 21 896
Andreia de Almeida Netherlands 21 516 0.6× 564 0.9× 432 0.8× 98 0.3× 146 1.0× 27 1.1k
Vojtěch Novohradský Czechia 28 1.2k 1.3× 950 1.6× 516 1.0× 119 0.4× 486 3.2× 60 1.9k
Raymond Wai‐Yin Sun China 14 519 0.6× 403 0.7× 247 0.5× 86 0.3× 248 1.6× 15 964

Countries citing papers authored by Loganathan Rangasamy

Since Specialization
Citations

This map shows the geographic impact of Loganathan Rangasamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loganathan Rangasamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loganathan Rangasamy more than expected).

Fields of papers citing papers by Loganathan Rangasamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loganathan Rangasamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loganathan Rangasamy. The network helps show where Loganathan Rangasamy may publish in the future.

Co-authorship network of co-authors of Loganathan Rangasamy

This figure shows the co-authorship network connecting the top 25 collaborators of Loganathan Rangasamy. A scholar is included among the top collaborators of Loganathan Rangasamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loganathan Rangasamy. Loganathan Rangasamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Guangrong, et al.. (2024). Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes. Pharmacology & Therapeutics. 263. 108725–108725. 13 indexed citations
2.
Rangasamy, Loganathan, et al.. (2024). A water-soluble colorimetric and turn-on fluorescence sensor for fast and sensitive detection of sulfite/bisulfite ions in real samples and live cells. Journal of Molecular Structure. 1321. 139723–139723. 9 indexed citations
3.
4.
Rangasamy, Loganathan, et al.. (2024). Mixed-ligand copper(ii)-diimine complexes of 3-formylchromone-N4-phenyl thiosemicarbazone: 5,6-dmp co-ligand confers enhanced cytotoxicity. RSC Advances. 14(43). 31704–31722. 10 indexed citations
5.
Ondari, Erick Nyakundi, et al.. (2024). Recent focus in non-SELEX-computational approach for de novo aptamer design: A mini review. Analytical Biochemistry. 699. 115756–115756. 6 indexed citations
6.
Rangasamy, Loganathan, et al.. (2024). Siderophore-Conjugated Antifungals: A Strategy to Potentially Cure Fungal Infections. ACS Infectious Diseases. 10(8). 2448–2466. 7 indexed citations
7.
Rangasamy, Loganathan, et al.. (2023). Mixed ligand copper(ii)-diimine complexes of 2-formylpyridine-N4-phenylthiosemicarbazone: diimine co-ligands tune thein vitronanomolar cytotoxicity. Dalton Transactions. 52(26). 9148–9169. 17 indexed citations
8.
Rangasamy, Loganathan, et al.. (2022). Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19. Molecular and Cellular Biochemistry. 478(7). 1487–1518. 4 indexed citations
9.
Rangasamy, Loganathan, et al.. (2022). A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery. Antibiotics. 11(12). 1717–1717. 11 indexed citations
10.
Rangasamy, Loganathan, et al.. (2022). A perspective to weaponize microRNAs against lung cancer. Non-coding RNA Research. 8(1). 18–32. 9 indexed citations
11.
Krishnan, Sasirekha, et al.. (2022). Recent developments of aptamer-based lateral flow assays for point-of-care (POC) diagnostics. Analytical Biochemistry. 655. 114874–114874. 31 indexed citations
12.
Rangasamy, Loganathan, Irene Ortín, José María Zapico, et al.. (2020). New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes. ACS Medicinal Chemistry Letters. 11(5). 713–719. 14 indexed citations
13.
Orellana, Esteban A., et al.. (2019). Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin. Molecular Therapy — Nucleic Acids. 16. 505–518. 29 indexed citations
14.
Rangasamy, Loganathan, Irene Ortín, Claire Coderch, et al.. (2019). Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs). Molecules. 24(16). 2982–2982. 43 indexed citations
15.
Rangasamy, Loganathan, Mani Ganeshpandian, Nattamai S. P. Bhuvanesh, et al.. (2017). DNA and protein binding, double-strand DNA cleavage and cytotoxicity of mixed ligand copper(II) complexes of the antibacterial drug nalidixic acid. Journal of Inorganic Biochemistry. 174. 1–13. 77 indexed citations
16.
Nikolić, Stefan, Loganathan Rangasamy, Nevenka Gligorijević, et al.. (2016). Synthesis, characterization and biological evaluation of novel Ru(II)–arene complexes containing intercalating ligands. Journal of Inorganic Biochemistry. 160. 156–165. 45 indexed citations
17.
Rangasamy, Loganathan, Sethu Ramakrishnan, Eringathodi Suresh, et al.. (2014). Mixed ligand μ-phenoxo-bridged dinuclear copper(ii) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity. Dalton Transactions. 43(16). 6177–6177. 94 indexed citations
18.
Ganeshpandian, Mani, Loganathan Rangasamy, Eringathodi Suresh, et al.. (2013). New ruthenium(ii) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity. Dalton Transactions. 43(3). 1203–1219. 189 indexed citations
19.
Rangasamy, Loganathan, et al.. (2013). Copper(ii) complexes with 2NO and 3N donor ligands: synthesis, structures and chemical nuclease and anticancer activities. Dalton Transactions. 42(23). 8347–8347. 98 indexed citations
20.
Rangasamy, Loganathan, Sethu Ramakrishnan, Eringathodi Suresh, et al.. (2012). Mixed Ligand Copper(II) Complexes of N,N-Bis(benzimidazol-2-ylmethyl)amine (BBA) with Diimine Co-Ligands: Efficient Chemical Nuclease and Protease Activities and Cytotoxicity. Inorganic Chemistry. 51(10). 5512–5532. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ritankar Majumdar Breakdown of academic impact, for papers by Catherine M. Clavel Breakdown of academic impact, for papers by Suzan Can Breakdown of academic impact, for papers by Hana Kostrhunová Breakdown of academic impact, for papers by Srividya Swaminathan Breakdown of academic impact, for papers by Yanglu Chen Breakdown of academic impact, for papers by Hannah E. Bridgewater Breakdown of academic impact, for papers by Andreia de Almeida Breakdown of academic impact, for papers by Vojtěch Novohradský Breakdown of academic impact, for papers by Raymond Wai‐Yin Sun
Rankless by CCL
2026